ReviewBiomaterials advances2022
Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines.
Romina Mitarotonda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it